Interested in seeing if you or a loved one qualifies for an Alzheimer’s disease (AD) clinical trial? Fill out the survey to see if you pre-qualify.
Your Experience Matters.
Help Researchers Learn More.
Alzheimer’s disease clinical trials are a critical part of finding potentially better treatments, especially for symptoms like memory loss, confusion, hallucinations and delusions that can deeply affect quality of life. If you or someone you care for is living with Alzheimer’s disease (AD) with symptoms of psychosis, you may qualify for a clinical trial near you. Participation is always voluntary, and there is no cost to enroll. Many studies may offer compensation, transportation, or additional support services.
We understand that choosing to participate in a study is a personal decision. That’s why we’re here to guide you through the process, answer your questions, and match you with the right research opportunities. Your experience is important — and it could potentially change the future of Alzheimer’s care.
What do Symptoms of Psychosis Look Like in Alzheimer’s Patients?
Symptoms may include:2
- Hallucinations: Seeing, hearing, or sensing things that aren’t there. A person might see people or animals in the room, hear voices, or believe someone is in the house when no one is there.
- Delusions: Strong false beliefs that don’t match reality. Common examples include thinking a spouse is an imposter, believing someone is stealing from them, or insisting they’re in danger or need to “go home” when they’re already at home.
- Paranoia: A form of delusion where the person may become suspicious, fearful, or mistrustful — even of loved ones or caregivers
- Accusatory Behavior: They may accuse others of lying, cheating, hiding things, or plotting against them.
These symptoms are more common in the moderate to severe stages of Alzheimer’s and can change over time. They often increase stress and caregiving challenges, and may require medical or behavioral interventions to manage safely. Clinical trials may help offer potential improvement.
What Do Current Treatments for Psychosis in Alzheimer’s Entail?
Psychosis in Alzheimer’s includes symptoms like hallucinations or delusions. This can be very upsetting for both the person with the disease and those around them. Doctors prescribe antipsychotic medications, but these carry risks for older adults with dementia, such as drowsiness, confusion, or even shorter lifespan.1 Because of this, there’s a strong need for better options. Clinical trials are investigating new study medications that may potentially reduce psychosis symptoms in Alzheimer’s disease patients. Learn more about if you or your loved one may pre-qualify.
Clinical Trials Make A Difference
Participation in a clinical study provides valuable information that could eventually lead to better treatment and outcomes. Take our short survey to see if you or a loved one may be a good fit. There is no obligation to participate if you pre-qualify.
See If You Pre-Qualify
FREQUENTLY ASKED QUESTIONS
What are the benefits of participating in an Alzheimer’s disease clinical trial?
The information gathered from clinical studies may help identify potential treatment options in the future for people living with AD. Study participants are often connected to specialists who understand their situation and can help answer questions from patients or their loved ones. Participants in research studies should also expect a professional clinical environment during the trial.
Who may be a good candidate to apply for an Alzheimer’s disease clinical trial?
You may consider applying for a study if you or a loved one:
- Are at least 55 years of age, and no older than 90
- Have a doctor-confirmed diagnosis of Alzheimer’s disease via PET scan, bloodwork, or MRI of the brain
- Exhibit signs of memory loss, confusion, agitation, restlessness, hallucinations or delusions
- Have a person in your/your loved one’s life with whom you/they spend 10 or more hours per week with on a regular basis who is willing and able to attend study visits, oversee medications, and help provide assessments (such as a spouse, caregiver, or an adult child)
What will happen during a clinical trial for Alzheimer’s disease?
Most clinical trials will involve frontline screening to confirm that a potential patient is, in fact, a match for that study’s criteria. Once verified and the patient has signed an Informed Consent Form, which clearly provides the details and purpose of the study to that individual and what it involves, participants can expect to attend scheduled appointments at a participating clinical research site. They will also receive a study drug (also called an investigational medication) and undergo additional screening and follow-up monitoring.
Are there any costs to participate in a clinical research study?
There is no cost to participate in a clinical trial. Participants receive all study-related medical care and study medications for the duration of the study at no cost. Likewise in many instances, study participants may receive travel and meal reimbursement and compensation.
Are there any risks to participating in a clinical research study?
All investigational drugs and medical procedures come with a risk of side effects. Participants may potentially experience some discomfort or other reactions during or after a clinical trial. The study staff should explain these potential risks before participants decide whether to join the trial and help address any concerns they may have.
Can a person change their mind about participating in a clinical study?
Yes. Participation in clinical trials is entirely voluntary. Even if a study participant is already involved in a study, they may change their mind, leave, or remove consent at any time, for any reason.
What if I have more questions?
If you are interested in learning more, please contact us at any time. You may email us at help@clinicalenrollment.com.
Still Have Questions?
Contact us anytime at help@clinicalenrollment.com.